Cellular senescence is involved in many disease processes but few senolytic compounds are currently known. Here, the authors report the discovery of three senolytics using machine learning models trained solely on published data, with large reductions in drug screening costs.
- Vanessa Smer-Barreto
- Andrea Quintanilla
- Diego A. Oyarzún
